v3.26.3
Revenue
9 Months Ended
Sep. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue

 

3.

Revenue

 

Disaggregation of Revenue

 

In general, the Company’s business segmentation is aligned according to the nature and economic characteristics of our services and provides meaningful disaggregation of each business segment’s results of operations. The nature of the Company’s performance obligations within our Treatment and Services Segments result in the recognition of our revenue primarily over time. The following tables present further disaggregation of our revenues by different categories for our Services and Treatment Segments:

 

                         
Revenue by Contract Type                        
(In thousands)  Three Months Ended   Three Months Ended 
   September 30, 2026   September 30, 2025 
   Treatment   Services   Total   Treatment   Services   Total 
Fixed price  $11,601   $1,446   $13,047   $13,114   $429   $13,543 
Time and materials   —     4,901    4,901    —     3,911    3,911 
Total  $11,601   $6,347   $17,948   $13,114   $4,340   $17,454 

 

                         
Revenue by Contract Type                        
(In thousands)  Nine Months Ended   Nine Months Ended 
   September 30, 2026   September 30, 2025 
   Treatment   Services   Total   Treatment   Services   Total 
Fixed price  $27,768   $1,962   $29,730   $33,696   $3,999   $37,695 
Time and materials   —     12,229    12,229    —     8,264    8,264 
Total  $27,768   $14,191   $41,959   $33,696   $12,263   $45,959 

 

                         
Revenue by generator                        
(In thousands)  Three Months Ended   Three Months Ended 
   September 30, 2026   September 30, 2025 
   Treatment   Services   Total   Treatment   Services   Total 
Domestic government  $7,621    5,064   $12,685   $9,204   $3,376   $12,580 
Domestic commercial   3,261    998    4,259    2,855    716    3,571 
Foreign government   399    251    650    859    160    1,019 
Foreign commercial   320    34    354    196    88    284 
Total  $11,601   $6,347   $17,948   $13,114   $4,340   $17,454 

 

                         
Revenue by generator                        
(In thousands)  Nine Months Ended   Nine Months Ended 
   September 30, 2026   September 30, 2025 
   Treatment   Services   Total   Treatment   Services   Total 
Domestic government  $17,909   $11,802   $29,711   $21,600   $10,661   $32,261 
Domestic commercial   7,855    1,927    9,782    7,644    1,161    8,805 
Foreign government   1,252    358    1,610    3,684    285    3,969 
Foreign commercial   752    104    856    768    156    924 
Total  $27,768   $14,191   $41,959   $33,696   $12,263   $45,959 

 

Revenues generated from fixed unit rate contracts within the Services Segment are included within the “time and material” caption under the disaggregation table above due to similarity of the revenue recognition methodology.

 

 

Contract Balances

 

The timing of revenue recognition and billings can result in unbilled receivables (contract assets). The Company’s contract liabilities consist of deferred revenues which represent advance payment from customers in advance of the completion of the Company’s performance obligation. The following table represents changes in our contract asset and contract liabilities balances for the periods noted:

 

           Year-to-date   Year-to-date 
(In thousands)  September 30, 2026   December 31, 2025   Change ($)   Change (%) 
Contract assets                
Unbilled receivables - current  $11,898   $8,781   $3,117    35.5%
                     
Contract liabilities                    
Deferred revenue  $10,036   $7,007   $3,029    43.2%

 

           Year-to-date   Year-to-date 
(In thousands)  September 30, 2025   December 31, 2024   Change ($)   Change (%) 
Contract assets                
Unbilled receivables - current  $8,396   $4,990   $3,406    68.3%
                     
Contract liabilities                    
Deferred revenue  $7,112   $6,711   $401    6.0%

 

During the three and nine months ended September 30, 2026, the Company recognized revenue of $1,488,000 and $8,804,000, respectively, related to untreated waste that was in the Company’s control as of the beginning of such respective period. During the three and nine months ended September 30, 2025, the Company recognized revenue of $752,000 and $4,640,000, respectively, related to untreated waste that was in the Company’s control as of the beginning of such respective period. Revenue recognized in each period related to performance obligations satisfied within the respective period.

 

Accounts Receivable

 

The following table represents changes in accounts receivable, net of credit losses, for the periods noted:

 

           Year-to-date   Year-to-date 
(In thousands)  September 30, 2026   December 31, 2025   Change ($)   Change (%) 
                 
Accounts Receivable (net)  $10,278   $11,228   $(950)   -8.5%

 

           Year-to-date   Year-to-date 
(In thousands)  September 30, 2025   December 31, 2024   Change ($)   Change (%) 
                 
Accounts Receivable (net)  $11,887   $11,579   $308    2.7%

 

Remaining Performance Obligations

 

The Company applies the practical expedient in Accounting Standards Codification (“ASC”) 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.

 

Within our Services Segment, there are service contracts which provide that the Company has a right to consideration from a customer in an amount that corresponds directly with the value to the customer of our performance completed to date. For those contracts, the Company has utilized the practical expedient in ASC 606-10-55-18, which allows the Company to recognize revenue in the amount for which we have the right to invoice; accordingly, the Company does not disclose the value of remaining performance obligations for those contracts.

 

The Company’s contracts and subcontracts relating to activities at governmental sites generally allow for termination for convenience at any time at the government’s option without payment of a substantial penalty. The Company does not disclose remaining performance obligations on these contracts.